Inhaled nitric oxide (NO) was shown to be an effective antibacterial agent against Mycobacterium abscessus infection in preclinical studies, as…
Alice Melão, MSc
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Alice Melão, MSc
A new therapy which is administered directly into the lung of viruses can kill bacteria, and was shown to be…
Cinnamon Oil Compound Might Block Bacteria Like P. aeruginosa from Forming Biofilms, Researchers Say
A natural component found in cinnamon oil, known as cinnamaldehyde or CAD, may be able to prevent Pseudomonas aeruginosa bacteria from…
Treating cystic fibrosis (CF) patients with the antibiotic azithromycin in addition to vitamin E supplements did not change their oxidative stress…
Children’s Hospital Colorado Part of Phase 3 Trial of Vertex’s Potential Triple Combo CF Therapy
The Mike McMorris Cystic Fibrosis Research and Care Center, part of the Children’s Hospital Colorado, is one of the…
Adding GLPG2737, Galapagos’ investigational CFTR corrector, to Vertex’s Orkambi (lumacaftor/ivacaftor) enhances the effectiveness of the treatment in…
Marine-Based Fatty Acids Can Reduce Inflammation, Improve Fat Absorption in CF Patients, Study Shows
Taking a marine-origin omega-3 compound, docosahexaenoic acid monoglyceride (MAG-DHA), can improve the absorption of fats and reduce inflammation in patients…
People ages 12 and older with cystic fibrosis (CF) who live in Canada can now be treated with…
The University of North Carolina (UNC) is among only a few institutions in the United States that offers patients with…
#ECFS2018 – Preclinical Data Shows Potential of ELX-02 to Reverse Effects of CFTR Nonsense Mutations
Preclinical studies show that Eloxx Pharmaceuticals’ lead therapy candidate ELX-02 can reverse the effects of CFTR gene nonsense…